Metabolomics of pancreatic juice, bile, and duodenal juice in patients with pancreatobiliary disease

Metabolomics of pancreatic juice, bile, and duodenal juice in patients with pancreatobiliary disease - Metabolomics of pancreatic juice, bile, and duodenal juice

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000045675

Enrollment

200

Registered

2021-10-18

Start date

2021-10-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatobiliary disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1)Patients with suspected pancreaticobiliary lesion by blood or imaging tests (2)Patients who require EUS/ERCP/EUS-FNA (3)Patients who have given written informed consent for study recruitment

Exclusion criteria

Exclusion criteria: (1)Patients who cannot undergo peroral endoscopic examination (2)Patients judged by the physician in charge to be inappropriate as research subjects

Design outcomes

Primary

Measure	Time frame
The differences of metabolomes in pancreatic juice/bile between malignant and benign pancreatobiliary diseases	—

Countries

Japan

Contacts

Public ContactMasaki Kuwatani

Hokkaido University Hospital Department of Gastroenterology and Hepatology

mkuwatan@med.hokudai.ac.jp011-716-1161

Outcome results